Clinical Trial Update: Severe Decrease of Growth Velocity in Children With Anorexia Nervosa.Therapeutic Trial of Growth Hormone [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial investigating growth hormone in children with anorexia nervosa showing severe growth velocity decrease and related bone health concerns…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anorexia Nervosa
• Delayed Puberty
• Interruption of Growth
• Osteopenia with Failure of Acquisition of Bone Mass

Drugs mentioned

• Growth Hormone (somatropin)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Anorexia Nervosa, Interruption of Growth | Phase 2, Phase 3 | Status: COMPLETED